Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Duxin Sun

Showing results (1-10 of 287) with videos related to

Pageof 29
Sort By:
The AAPS Journal|May 28, 2020
Remdesivir for Treatment of COVID-19: Combination of Pulmonary and IV Administration May Offer Aditional BenefitDuxin Sun
The AAPS Journal|August 4, 2020
Correction to: Remdesivir for Treatment of COVID-19: Combination of Pulmonary and IV Administration May Offer Additional BenefitDuxin Sun
Molecular Pharmaceutics|December 7, 2010
Nanotheranostics: integration of imaging and targeted drug deliveryDuxin Sun
Expert Opinion on Drug Discovery|March 20, 2013
Anthracyclines as effective anticancer drugsJanos Nadas, Duxin Sun
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 22, 2008
Predictive physiologically based pharmacokinetic model for antibody-directed enzyme prodrug therapyLanyan Fang, Duxin Sun
Expert Review of Clinical Pharmacology|November 25, 2011
Superparamagnetic iron oxide nanoparticle 'theranostics' for multimodality tumor imaging, gene delivery, targeted drug and prodrug deliveryYanke Yu, Duxin Sun
International Journal of Pharmaceutics|December 1, 2009
Biodistribution of HuCC49DeltaCH2-beta-galactosidase in colorectal cancer xenograft modelYanke Yu, Lanyan Fang, Duxin Sun
The AAPS Journal|October 29, 2024
Exploring the Impact of Pharmacological Target-Mediated Low Plasma Exposure in Lead Compound Selection in Drug Discovery - A Modeling ApproachMin Xu, Duxin Sun, Guohua An
ACS Nano|October 6, 2020
What Went Wrong with Anticancer Nanomedicine Design and How to Make It RightDuxin Sun, Simon Zhou, Wei Gao
Current Drug Targets|May 19, 2012
Targeting cancer stem cells with natural productsJoseph Burnett, Bryan Newman, Duxin Sun
Pageof 29

Showing results (1-10 of 287) with videos related to

Sort By:
Pageof 29
The AAPS Journal|May 28, 2020
Remdesivir for Treatment of COVID-19: Combination of Pulmonary and IV Administration May Offer Aditional BenefitDuxin Sun
The AAPS Journal|August 4, 2020
Correction to: Remdesivir for Treatment of COVID-19: Combination of Pulmonary and IV Administration May Offer Additional BenefitDuxin Sun
Molecular Pharmaceutics|December 7, 2010
Nanotheranostics: integration of imaging and targeted drug deliveryDuxin Sun
Expert Opinion on Drug Discovery|March 20, 2013
Anthracyclines as effective anticancer drugsJanos Nadas, Duxin Sun
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 22, 2008
Predictive physiologically based pharmacokinetic model for antibody-directed enzyme prodrug therapyLanyan Fang, Duxin Sun
Expert Review of Clinical Pharmacology|November 25, 2011
Superparamagnetic iron oxide nanoparticle 'theranostics' for multimodality tumor imaging, gene delivery, targeted drug and prodrug deliveryYanke Yu, Duxin Sun
International Journal of Pharmaceutics|December 1, 2009
Biodistribution of HuCC49DeltaCH2-beta-galactosidase in colorectal cancer xenograft modelYanke Yu, Lanyan Fang, Duxin Sun
The AAPS Journal|October 29, 2024
Exploring the Impact of Pharmacological Target-Mediated Low Plasma Exposure in Lead Compound Selection in Drug Discovery - A Modeling ApproachMin Xu, Duxin Sun, Guohua An
ACS Nano|October 6, 2020
What Went Wrong with Anticancer Nanomedicine Design and How to Make It RightDuxin Sun, Simon Zhou, Wei Gao
Current Drug Targets|May 19, 2012
Targeting cancer stem cells with natural productsJoseph Burnett, Bryan Newman, Duxin Sun
Pageof 29